MediFind
Condition

Huntington Disease

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: Huntington Disease (HD)
  • Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
  • Treatment Used: Medical Marijuana
  • Number of Patients: 0
  • Published —
This review of the literature evaluated the effects of medical marijuana on symptoms that are relevant to movement disorders, focusing on Huntington disease (HD).
Latest Advance
Study
  • Condition: Chorea
  • Journal: Tremor and other hyperkinetic movements (New York, N.Y.)
  • Treatment Used: Various
  • Number of Patients: 0
  • Published —
The study researched the outcomes of treating chorea in patients with infectious, pharmacologic, metabolic, autoimmune disorders, or paraneoplastic syndromes.
Latest Advance
Study
  • Condition: Huntington disease
  • Journal: Neurology
  • Treatment Used: Physical therapy
  • Number of Patients: 0
  • Published —
The study researched the effects of physical therapy on patients with Huntington disease.
Latest Advance
Study
  • Condition: Huntington's Disease-Associated Tardive Dyskinesia and Chorea
  • Journal: Expert opinion on pharmacotherapy
  • Treatment Used: Deutetrabenazine
  • Number of Patients: 0
  • Published —
This study evaluated the use of deutetrabenazine in patients with Huntington's disease-associated tardive dyskinesia and chorea.
Latest Advance
Study
  • Condition: Huntington's Disease (HD)
  • Journal: Tremor and other hyperkinetic movements (New York, N.Y.)
  • Treatment Used: Complementary and Alternative Medicine (CAM)
  • Number of Patients: 0
  • Published —
This review of the literature summarized the available evidence for various mind-body practices and nutraceuticals in the use of complementary and alternative medicine (CAM) for Huntington's disease (HD).
Latest Advance
Study
  • Condition: Neurodegenerative Diseases
  • Journal: Annual review of neuroscience
  • Treatment Used: Antisense Oligonucleotide Therapies
  • Number of Patients: 0
  • Published —
This article discusses antisense oligonucleotide therapies for neurodegenerative diseases.
Latest Advance
Study
  • Condition: Huntington disease
  • Journal: Acta neuropsychiatrica
  • Treatment Used: Ethyl-eicosapentaenoic acid
  • Number of Patients: 0
  • Published —
The study researched the effects of ethyl-eicosapentaenoic acid (medication) in treating Huntington disease.
Latest Advance
Study
  • Condition: Huntington's disease
  • Journal: The Lancet. Neurology
  • Treatment Used: Pridopidine
  • Number of Patients: 408
  • Published —
The study researched the outcomes of pridopidine in patients with Huntington's disease.
Latest Advance
Study
  • Condition: Stroke
  • Journal: Nutritional neuroscience
  • Treatment Used: Coenzyme Q10 Supplementation
  • Number of Patients: 90
  • Published —
The study researched the effects of coenzyme Q10 supplementation for patients before or after a stroke.
Latest Advance
Study
  • Condition: Huntington's disease
  • Journal: Acta neurologica Scandinavica
  • Treatment Used: multidisciplinary therapy
  • Number of Patients: 22
  • Published —
The purpose of the study was to evaluate the effects of outpatient multidisciplinary therapy compared to usual care on measures of physical function and muscle strength in patients with Huntington's disease.